• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Mumbai , Dec. 26

Claris Lifesciences Ltd has raised $25 million (Rs 110 crore) through external commercial borrowings. Barclays Capital was the lead arranger for the issue.

The ECB marks the second fund raising done by Claris this fiscal, after Carlyle's investment in the form of private equity.

"The funds will be targeted at building capacities for the regulated markets, as well as for developing new products," said Mr Sushil Handa, Founder, Claris Lifesciences Ltd.

Claris Lifesciences is in the business of manufacturing and marketing sterile parenteral preparations, life saving medicines and hospital products focusing on delivery systems.

More Stories on : Overseas Borrowings | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Dr Reddy's diabetic drug enters phase I trials

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line